Northera
Drug
Lundbeck LLC
Total Payments
$38,068
Transactions
26
Doctors
2
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2018 | $16,268 | 10 | 2 |
| 2017 | $21,800 | 16 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Charitable Contribution | $21,800 | 16 | 57.3% |
| Unspecified | $16,112 | 4 | 42.3% |
| Food and Beverage | $86.09 | 4 | 0.2% |
| Travel and Lodging | $70.24 | 2 | 0.2% |
Payments by Type
General
$21,956
22 transactions
Research
$16,112
4 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Northera Improves Postural Tachycardia Syndrome (POTS) and Postural Vasovagal Syncope (VVS) | Lundbeck LLC | $11,803 | 0 |
| Norepinephrine-targeted Therapy for Action Control in Parkinson Disease | Lundbeck LLC | $3,057 | 0 |
| N/A | Lundbeck LLC | $679.34 | 0 |
| Brain Perfusion & Oxygenation in Parkinson's Disease With NOH | Lundbeck LLC | $572.44 | 0 |
Ad
Manufacturing Companies
- Lundbeck LLC $38,068
Product Information
- Type Drug
- Total Payments $38,068
- Total Doctors 2
- Transactions 26
About Northera
Northera is a drug associated with $38,068 in payments to 2 healthcare providers, recorded across 26 transactions in the CMS Open Payments database. The primary manufacturer is Lundbeck LLC.
Payment data is available from 2017 to 2018. In 2018, $16,268 was paid across 10 transactions to 2 doctors.
The most common payment nature for Northera is "Charitable Contribution" ($21,800, 57.3% of total).
Northera is associated with 4 research studies, including "Northera Improves Postural Tachycardia Syndrome (POTS) and Postural Vasovagal Syncope (VVS)" ($11,803).